Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pramipexole in progressive supranuclear palsy.

W J Weiner1, A Minagar, L M Shulman

  • 1Department of Neurology, University of Miami School of Medicine, FL 33136, USA.

Neurology
|March 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-expanding intestinal expansion sleeves (IES) for short gut syndrome.

Pediatric surgery international·2021
Same author

The inconsistency and instability of Parkinson's disease motor subtypes.

Parkinsonism & related disorders·2021
Same author

Neurolymphatic biomarkers of brain endothelial inflammatory activation: Implications for multiple sclerosis diagnosis.

Life sciences·2019
Same author

Viruses with Circular Single-Stranded DNA Genomes Are Everywhere!

Annual review of virology·2017
Same author

Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Sexual interactions with unfamiliar females reduce hippocampal neurogenesis among adult male rats.

Neuroscience·2016
Same journal

Teaching Video NeuroImage: Tardive Blepharoclonus.

Neurology·2026
Same journal

Teaching NeuroImage: Latent Axonal Degeneration in Patient With Anterior Circulation Stroke.

Neurology·2026
Same journal

Incidental DWI-Positive Lesions in 2 Cohorts of CAA and CADASIL: Prevalence, Distribution, and Associations With Clinical Variables.

Neurology·2026
Same journal

Alpha-Synuclein Seed Amplification Assay in CSF, Skin, and Submandibular Gland From Incidental Lewy Body Disease and Parkinson Disease.

Neurology·2026
Same journal

Digital Semiology.

Neurology·2026
Same journal

Early Cerebral Edema Subtypes and Functional Outcome in Patients With Cerebral Venous Thrombosis: Insights From the CLOT-VENUS Registry.

Neurology·2026
See all related articles

Pramipexole did not improve symptoms in patients with progressive supranuclear palsy (PSP). This study found no efficacy for pramipexole in treating this neurodegenerative disorder.

Area of Science:

  • Neurology
  • Neurodegenerative Diseases
  • Clinical Pharmacology

Background:

  • Progressive supranuclear palsy (PSP) is a rare, fatal neurodegenerative disease.
  • Currently, no effective treatments exist for PSP.
  • Dopaminergic agents may offer temporary relief for some PSP symptoms.

Purpose of the Study:

  • To evaluate the efficacy of pramipexole in treating the symptoms of progressive supranuclear palsy.
  • To assess the safety and tolerability of pramipexole in PSP patients.

Main Methods:

  • A clinical trial involving six patients diagnosed with PSP.
  • Patients received a daily dosage of 4.5 mg of pramipexole for two months.
  • Standardized scales (Unified Parkinson's Disease Rating Scale, Hoehn and Yahr, Schwab and England Activities of Daily Living) were used for evaluation.

Related Experiment Videos

Main Results:

  • Pramipexole treatment did not demonstrate significant efficacy in improving PSP symptoms.
  • No substantial changes were observed in patient evaluations after two months of treatment.
  • The drug was generally tolerated, but failed to provide therapeutic benefit.

Conclusions:

  • Pramipexole is not an effective treatment for the symptoms associated with progressive supranuclear palsy.
  • Further research is needed to identify effective therapies for PSP.
  • This study highlights the limited treatment options currently available for PSP patients.